Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $460.52 | 27 | 86.0% |
| Education | $74.99 | 1 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $86.66 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $82.65 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $74.99 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $69.12 | 4 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $39.54 | 3 | $0 (2024) |
| Novo Nordisk Inc | $37.13 | 2 | $0 (2024) |
| Acclarent, Inc | $36.87 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.41 | 2 | $0 (2018) |
| Currax Pharmaceuticals LLC | $16.32 | 1 | $0 (2024) |
| PFIZER INC. | $15.86 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122.64 | 7 | ABBVIE INC. ($39.93) |
| 2023 | $16.80 | 1 | ABBVIE INC. ($16.80) |
| 2021 | $69.34 | 2 | GlaxoSmithKline, LLC. ($39.41) |
| 2019 | $52.06 | 3 | Janssen Pharmaceuticals, Inc ($39.70) |
| 2018 | $99.41 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($27.41) |
| 2017 | $175.26 | 8 | Astellas Pharma US Inc ($74.99) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Respiratory | ||||||
| 04/04/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Diabetes | ||||||
| 04/02/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Obesity | ||||||
| 02/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $39.41 | General |
| Category: VACCINES | ||||||
| 08/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Respiratory | ||||||
| 09/04/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Diabetes | ||||||
| 06/04/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/23/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/28/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: VACCINES | ||||||
| 03/21/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/10/2018 | Acclarent, Inc | ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Rhinology, Otology | ||||||
| 12/06/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Respiratory | ||||||
| 11/29/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 11/14/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: OBESITY | ||||||
| 10/03/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,064 | 1,719 | $437,117 | $131,297 |
| 2022 | 16 | 957 | 1,580 | $411,322 | $122,825 |
| 2021 | 19 | 1,083 | 1,591 | $396,875 | $119,354 |
| 2020 | 22 | 1,205 | 1,668 | $387,122 | $103,229 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 373 | 793 | $252,967 | $68,569 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 223 | 223 | $75,597 | $28,203 | 37.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 39 | 44 | $23,848 | $7,012 | 29.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 114 | $13,908 | $5,468 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 64 | $14,016 | $3,720 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $12,506 | $2,929 | 23.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $9,308 | $2,807 | 30.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $8,000 | $2,588 | 32.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 31 | 31 | $2,604 | $2,350 | 90.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $5,856 | $1,945 | 33.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 63 | 103 | $6,901 | $1,674 | 24.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 34 | $3,094 | $1,255 | 40.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 21 | 26 | $4,212 | $1,012 | 24.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $925.00 | $906.50 | 98.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 51 | 91 | $910.00 | $292.11 | 32.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $1,100 | $247.06 | 22.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 25 | $1,050 | $220.40 | 21.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 36 | 45 | $315.00 | $99.00 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 346 | 872 | $278,168 | $78,107 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 204 | 204 | $69,156 | $26,253 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 88 | $19,272 | $5,304 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $12,506 | $2,865 | 22.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 13 | $7,046 | $2,081 | 29.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $5,856 | $1,976 | 33.7% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 14 | 14 | $1,680 | $1,321 | 78.6% |
About Dr. Sandra Garred, M.D
Dr. Sandra Garred, M.D is a Internal Medicine healthcare provider based in Fredericksburg, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770578478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Garred, M.D has received a total of $535.51 in payments from pharmaceutical and medical device companies, with $122.64 received in 2024. These payments were reported across 28 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($460.52).
As a Medicare-enrolled provider, Garred has provided services to 4,309 Medicare beneficiaries, totaling 6,558 services with total Medicare billing of $476,705. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Fredericksburg, TX
- Active Since 09/19/2005
- Last Updated 06/07/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770578478
Products in Payments
- UBRELVY (Drug) $65.15
- XARELTO (Drug) $55.39
- SHINGRIX (Biological) $54.14
- TRELEGY ELLIPTA (Drug) $28.51
- Trintellix (Drug) $27.41
- CONTRAVE (Drug) $26.74
- Rybelsus (Drug) $24.55
- VRAYLAR (Drug) $21.51
- ACCLARENT AERA Eustachian Tube Balloon Dilation System (Device) $20.66
- ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM (Device) $16.21
- PREVNAR - 13 (Biological) $15.86
- PRECISION PLUS SCS SYSTEM (Device) $14.20
- INVOKANA (Drug) $13.73
- BEVESPI AEROSPHERE (Drug) $13.42
- AIRSUPRA (Drug) $13.33
- SYMBICORT (Drug) $12.79
- Victoza (Drug) $12.58
- ENTRESTO (Drug) $12.36
- FORTEO (Drug) $11.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fredericksburg
Matthew Whitehurst, Md, MD
Internal Medicine — Payments: $34,621
Kenneth Mcdowell, Do, DO
Internal Medicine — Payments: $17,181
Dr. Norman Chang, M.d, M.D
Internal Medicine — Payments: $11,733
Dr. Veena Vangani, Md, MD
Internal Medicine — Payments: $11,338
Dr. Ethan Ko, Do, DO
Internal Medicine — Payments: $10,053
Dr. Bozena Wolanska, M.d, M.D
Internal Medicine — Payments: $9,531